UB Paderborn / Katalog / Suche / in CDI

P010 Precision Dosing Tool Forecasts Trough Infliximab and Associates With Disease Status in Inflammatory Bowel Diseases

The American journal of gastroenterology, 2021-12, Vol.116 (Suppl 1), p.S3-S3

2021

Link zum Volltext

Verfügbarkeit prüfen

Model Informed Precision Dosing Tool Forecasts Trough Infliximab and Associates with Disease Status and Tumor Necrosis Factor-Alpha Levels of Inflammatory Bowel Diseases

Journal of clinical medicine, 2022-06, Vol.11 (12), p.3316

2022

Link zum Volltext

Verfügbarkeit prüfen

Drug monitoring of biologics in inflammatory bowel disease

Current opinion in gastroenterology, 2013-07, Vol.29 (4), p.391-396

2013

Link zum Volltext

Verfügbarkeit prüfen

Induction Efficacy of Upadacitinib in Therapy-Refractory Crohn’s Disease: A Retrospective Case Series

Clinical gastroenterology and hepatology, 2023-02, Vol.21 (2), p.532-534.e3

2023

Link zum Volltext

Verfügbarkeit prüfen

Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial

Gut, 2023-04, Vol.72 (4), p.644

2023

Link zum Volltext

Verfügbarkeit prüfen

Was der Kliniker vom Radiologen wissen will

Gastro-News, 2018-10, Vol.5 (5), p.30-37

2018

Link zum Volltext

Verfügbarkeit prüfen

Humoral response to COVID-19 infection in immunosuppressed patients with inflammatory bowel disease

European journal of gastroenterology & hepatology, 2021-03, Vol.33 (3), p.443

2021

Link zum Volltext

Verfügbarkeit prüfen

Role of fecal calprotection in predicting endoscopic recurrence in postoperative Crohn's disease

Scandinavian journal of gastroenterology, 2021-10, Vol.56 (10), p.1169-1174

2021

Link zum Volltext

Verfügbarkeit prüfen

Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2021-10, Vol.161 (4), p.1245-1256.e20

2021

Link zum Volltext

Verfügbarkeit prüfen

Prediction of Individual Serum Infliximab Concentrations in Inflammatory Bowel Disease by a Bayesian Dashboard System

Journal of clinical pharmacology, 2018-06, Vol.58 (6), p.790-802

2018

Link zum Volltext

Verfügbarkeit prüfen

Passive Smoking Increases the Risk for Intestinal Surgeries in Patients With Crohn’s Disease

Inflammatory bowel diseases, 2021-03, Vol.27 (3), p.379-385

2021

Link zum Volltext

Verfügbarkeit prüfen

Tu1900 A PHARMACOKINETIC (PK) AND SAFETY STUDY OF A FIMH BLOCKER, SIBOFIMLOC (TAK-018/EB8018), IN PATIENTS WITH CROHN'S DISEASE (CD)

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-1211-S-1212

2020

Link zum Volltext

Verfügbarkeit prüfen

Crohn’s disease: prevalence, MR features, and clinical significance of enteric and colonic sinus tracts

European radiology, 2020-10, Vol.30 (10), p.5358-5366

2020

Link zum Volltext

Verfügbarkeit prüfen

Su436 INITIAL CLEARANCE OF INFLIXIMAB IS A PREDICTOR FOR LONG-TIME MUCOSAL HEALING AND BIOMARKER RESPONSE

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-688-S-688

2021

Link zum Volltext

Verfügbarkeit prüfen

Safety, pharmacokinetic, and pharmacodynamic study of sibofimloc, a novel FimH blocker in patients with active Crohn's disease

Journal of gastroenterology and hepatology, 2022-05, Vol.37 (5), p.832-840

2022

Link zum Volltext

Verfügbarkeit prüfen

Platelets Toll‐like receptor‐4 in Crohns disease

European journal of clinical investigation, 2017-02, Vol.47 (2), p.109-116

2017

Link zum Volltext

Verfügbarkeit prüfen

A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease

Scandinavian journal of gastroenterology, 2015-01, Vol.50 (10), p.1226-1233

2015

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory Bowel Disease and Risk of Major Bleeding During Anticoagulation for Venous Thromboembolism

Inflammatory bowel diseases, 2021-10, Vol.27 (11), p.1773-1783

2021

Link zum Volltext

Verfügbarkeit prüfen

Thumb sucking or nail biting in childhood and adolescence is associated with an increased risk of Crohn's disease: results from a large case-control study

Scandinavian journal of gastroenterology, 2020-09, Vol.55 (9), p.1028-1034

2020

Link zum Volltext

Verfügbarkeit prüfen

Factors impacting the results of interferon‐γ release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases

Inflammatory bowel diseases, 2011-01, Vol.17 (1), p.84-90

2011

Link zum Volltext

Verfügbarkeit prüfen

Portal hypertensive gastropathy is associated with iron deficiency anemia

Wiener Klinische Wochenschrift, 2020, Vol.132 (1-2), p.1-11

2020

Link zum Volltext

Verfügbarkeit prüfen

P010 Precision Dosing Tool Forecasts Trough Infliximab and Associates With Disease Status in Inflammatory Bowel Diseases

The American journal of gastroenterology, 2021-12, Vol.116 (Suppl 1), p.S3

2021

Link zum Volltext

Verfügbarkeit prüfen

443 – Intestinal Biofilms are an Endoscopic Feature of Irritable Bowel Syndrome

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-92-S-92

2019

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

P010 Precision Dosing Tool Forecasts Trough Infliximab and Associates With Disease Status in Inflammatory Bowel Diseases

Model Informed Precision Dosing Tool Forecasts Trough Infliximab and Associates with Disease Status and Tumor Necrosis Factor-Alpha Levels of Inflammatory Bowel Diseases

Drug monitoring of biologics in inflammatory bowel disease

Factors Associated with Response to Systemic Corticosteroids in Active Ulcerative Colitis: Results from a Prospective, Multicenter Trial

Induction Efficacy of Upadacitinib in Therapy-Refractory Crohn’s Disease: A Retrospective Case Series

Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial

Was der Kliniker vom Radiologen wissen will

Humoral response to COVID-19 infection in immunosuppressed patients with inflammatory bowel disease

Role of fecal calprotection in predicting endoscopic recurrence in postoperative Crohn's disease

Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative Colitis

Prediction of Individual Serum Infliximab Concentrations in Inflammatory Bowel Disease by a Bayesian Dashboard System

Passive Smoking Increases the Risk for Intestinal Surgeries in Patients With Crohn’s Disease

Tu1900 A PHARMACOKINETIC (PK) AND SAFETY STUDY OF A FIMH BLOCKER, SIBOFIMLOC (TAK-018/EB8018), IN PATIENTS WITH CROHN'S DISEASE (CD)

Crohn’s disease: prevalence, MR features, and clinical significance of enteric and colonic sinus tracts

Su436 INITIAL CLEARANCE OF INFLIXIMAB IS A PREDICTOR FOR LONG-TIME MUCOSAL HEALING AND BIOMARKER RESPONSE

Safety, pharmacokinetic, and pharmacodynamic study of sibofimloc, a novel FimH blocker in patients with active Crohn's disease

Prediction of Response to Systemic Corticosteroids in Active UC by Microbial Composition—A Prospective Multicenter Study

Platelets Toll‐like receptor‐4 in Crohns disease

A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease

Inflammatory Bowel Disease and Risk of Major Bleeding During Anticoagulation for Venous Thromboembolism

Thumb sucking or nail biting in childhood and adolescence is associated with an increased risk of Crohn's disease: results from a large case-control study

Factors impacting the results of interferon‐γ release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases

Portal hypertensive gastropathy is associated with iron deficiency anemia

P010 Precision Dosing Tool Forecasts Trough Infliximab and Associates With Disease Status in Inflammatory Bowel Diseases

443 – Intestinal Biofilms are an Endoscopic Feature of Irritable Bowel Syndrome

Suchergebnisse filtern